Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2017 (2017), Article ID 1073146, 4 pages
https://doi.org/10.1155/2017/1073146
Case Report

Pneumocystis Pneumonia in Non-HIV Pregnant Women Receiving Chemotherapy for Malignant Lymphoma: Two Case Reports

Department of Gynecology and Obstetrics, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

Correspondence should be addressed to Yoshitsugu Chigusa

Received 2 April 2017; Revised 28 July 2017; Accepted 2 August 2017; Published 28 August 2017

Academic Editor: Akihide Ohkuchi

Copyright © 2017 Yuki Fukutani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. G. Mansharamani, R. Garland, D. Delaney, and H. Koziel, “Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states,” Chest, vol. 118, no. 3, pp. 704–711, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Tamaki, F. Higa, D. Tasato et al., “Pneumocystis jirovecii pneumonia and alveolar hemorrhage in a pregnant woman with human T cell lymphotropic virus type-1 infection,” Internal Medicine, vol. 50, no. 4, pp. 351–354, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Brenner, I. Avivi, and M. Lishner, “Haematological cancers in pregnancy,” The Lancet, vol. 379, no. 9815, pp. 580–587, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Avilés and N. Neri, “Hematological malignancies and pregnancy: A final report of 84 children who received chemotherapy in utero,” Clinical Lymphoma, vol. 2, no. 3, pp. 173–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Pfreundschuh, L. Trümper, A. Österborg et al., “CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group,” The Lancet Oncology, vol. 7, no. 5, pp. 379–391, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. E. F. Chakravarty, E. R. Murray, A. Kelman, and P. Farmer, “Pregnancy outcomes after maternal exposure to rituximab,” Blood, vol. 117, no. 5, pp. 1499–1506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. E. J. Lee, K. H. Ahn, S. C. Hong, E. H. Lee, Y. Park, and B. S. Kim, “Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth,” Obstetrics & Gynecology Science, vol. 57, no. 6, pp. 526–529, 2014. View at Publisher · View at Google Scholar
  8. P. K. Mandal, T. K. Dolai, B. Bagchi, M. K. Ghosh, S. Bose, and M. Bhattacharyya, “B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen,” Indian Journal of Pediatrics, vol. 81, no. 10, pp. 1092–1094, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. T. R. Zembower, “Epidemiology of infections in cancer patients,” Cancer Treatment and Research, vol. 161, pp. 43–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Hardak, I. Oren, E. J. Dann et al., “The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience,” Acta Haematologica, vol. 127, no. 2, pp. 110–114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kalin, S. Y. Kristinsson, H. Cherif, M. Lebbad, and M. Björkholm, “Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients,” Annals of Hematology, vol. 89, no. 5, pp. 523–525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Luppi, “How immune mechanisms are affected by pregnancy,” Vaccine, vol. 21, no. 24, pp. 3352–3357, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. C. F. Thomas Jr. and A. H. Limper, “Pneumocystis pneumonia,” The New England Journal of Medicine, vol. 350, no. 24, pp. 2487–2498, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Bozzette, D. M. Finkelstein, and S. A. Spector, “A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection,” The New England Journal of Medicine, vol. 332, no. 11, pp. 693–699, 1995. View at Publisher · View at Google Scholar
  15. N. Ford, Z. Shubber, J. Jao, E. J. Abrams, L. Frigati, and L. Mofenson, “Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis,” Journal of Acquired Immune Deficiency Syndromes, vol. 66, no. 5, pp. 512–521, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. A. H. Limper, K. S. Knox, G. A. Sarosi et al., “An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 1, pp. 96–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Goldberg-Stein, B. Liu, P. F. Hahn, and S. I. Lee, “Body CT during pregnancy: Utilization trends, examination indications, and fetal radiation doses,” American Journal of Roentgenology, vol. 196, no. 1, pp. 146–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Lazarus, C. DeBenedectis, D. North, P. K. Spencer, and W. W. Mayo-Smith, “Utilization of imaging in pregnant patients: 10-year review of 5270 examinations in 3285 patients - 1997–2006,” Radiology, vol. 251, no. 2, pp. 517–524, 2009. View at Publisher · View at Google Scholar · View at Scopus